Breakthrough therapies don’t reach patients by science alone—it takes regulatory leadership under pressure.

In this episode of GURU Gab, Kavitha speaks with Judy Kannenberg on making high-stakes decisions, building resilient teams, and why AI is already shaping regulatory strategy.

Key insights:
• The 80/20 reality of regulatory decision-making
• Leadership beyond technical expertise
• The power of communication and resilience
• Why AI adoption is no longer optional

If you work in pharma, regulatory, or medical affairs—this conversation is for you.